TABLE 1.
Factor | Control group | OPAT group |
---|---|---|
n | 21 | 21 |
Age, years, mean ± SD | 59.1±17.3 | 58.8±17.2 |
Female sex | 9 (42.9) | 9 (42.9) |
Procedure | ||
Neurosurgery | 5 (23.8) | 5 (23.8) |
Vascular surgery | 2 (9.5) | 2 (9.5) |
Cardiovascular surgery | 6 (28.6) | 6 (28.6) |
Orthopedic surgery | 8 (38.1) | 8 (38.1) |
Infection | ||
Osteomyelitis | 7 (33.3) | 7 (33.3) |
Joint (endogenous) | 1 (4.8) | 1 (4.8) |
Joint (prosthetic) | 7 (33.3) | 7 (33.3) |
Vascular graft | 1 (4.8) | 1 (4.8) |
Endocarditis/pacemaker | 4 (19.0) | 4 (19.0) |
Brain abscess | 1 (4.8) | 1 (4.8) |
Charlson Comorbidity Index, mean | 1.33 | 1.33 |
Source control achieved | 17 (81.0) | 19 (90.4) |
Treatment duration, days, mean ± SD | 39.0±6.9 | 42.7±5.4 |
Data presented as n (%) unless otherwise specified. OPAT Outpatient parenteral antimicrobial therapy